Pavel ME, Dromain C, Thanh TXM, Houchard A (2019)
Publication Type: Conference contribution
Publication year: 2019
Publisher: KARGER
City/Town: BASEL
Pages Range: 157-157
Conference Proceedings Title: NEUROENDOCRINOLOGY
APA:
Pavel, M.E., Dromain, C., Thanh, T.X.M., & Houchard, A. (2019). Safety and Efficacy of 14-Day Dosing Interval of Lanreotide Autogel/Depot (LAN) for Pts with Pancreatic or Midgut Neuroendocrine Tumours (NETs) Progressing on LAN Every 28 Days: Prospective, Open-label, International, Phase 2 CLARINET FORTE Study. In NEUROENDOCRINOLOGY (pp. 157-157). BASEL: KARGER.
MLA:
Pavel, Marianne Ellen, et al. "Safety and Efficacy of 14-Day Dosing Interval of Lanreotide Autogel/Depot (LAN) for Pts with Pancreatic or Midgut Neuroendocrine Tumours (NETs) Progressing on LAN Every 28 Days: Prospective, Open-label, International, Phase 2 CLARINET FORTE Study." Proceedings of the NEUROENDOCRINOLOGY BASEL: KARGER, 2019. 157-157.
BibTeX: Download